LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 68.37 | 27.76 | 5 | 6879 | 0.0007 | -0.1939 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 68.37 | 27.76 | 668 | 6879 | 0.0971 | 0.4917 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 70.08 | 27.76 | 36 | 6849 | 0.0053 | 0.0333 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 70.08 | 27.76 | 627 | 6849 | 0.0915 | 0.4804 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 70.08 | 27.76 | 5 | 6849 | 0.0007 | -0.1940 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 70.08 | 27.76 | 670 | 6849 | 0.0978 | 0.4928 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 71.78 | 27.76 | 25 | 6893 | 0.0036 | -0.0131 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 71.78 | 27.76 | 621 | 6893 | 0.0901 | 0.4779 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 71.78 | 27.76 | 2 | 6893 | 0.0003 | -0.2815 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 71.78 | 27.76 | 640 | 6893 | 0.0928 | 0.4835 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 73.48 | 27.76 | 16 | 6957 | 0.0023 | -0.0668 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 73.48 | 27.76 | 605 | 6957 | 0.0870 | 0.4721 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 73.48 | 27.76 | 5 | 6957 | 0.0007 | -0.1935 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 73.48 | 27.76 | 610 | 6957 | 0.0877 | 0.4736 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 75.19 | 27.76 | 15 | 7015 | 0.0021 | -0.0742 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 75.19 | 27.76 | 606 | 7015 | 0.0864 | 0.4716 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 75.19 | 27.76 | 5 | 7015 | 0.0007 | -0.1933 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 75.19 | 27.76 | 599 | 7015 | 0.0854 | 0.4694 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 76.89 | 27.76 | 13 | 7025 | 0.0019 | -0.0906 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 76.89 | 27.76 | 610 | 7025 | 0.0868 | 0.4726 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 76.89 | 27.76 | 3 | 7025 | 0.0004 | -0.2432 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 76.89 | 27.76 | 591 | 7025 | 0.0841 | 0.4668 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 78.60 | 27.76 | 15 | 7045 | 0.0021 | -0.0742 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 78.60 | 27.76 | 605 | 7045 | 0.0859 | 0.4708 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 78.60 | 27.76 | 2 | 7045 | 0.0003 | -0.2806 | MN20160318_Q01 | K20 |